1 Min Read
FRANKFURT, May 20 (Reuters) - Morphosys AG : * Says mor208 program to receive orphan drug designation from FDA and ema for
the treatment of cll/sll
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.